ZTS
Zoetis
November 4, 2026 · intraday
- Rarity
- 1.47
- Peak move
- +5.75%
- Float cap
- $35.1B
Still running — rarity and peak move can only rise from here.
Zoetis is a global animal health company that discovers, develops and manufactures medicines, vaccines, diagnostics and genetic tests. It sells to veterinarians, pet owners and livestock producers across eight core species: dogs, cats and horses on the companion-animal side, and cattle, swine, poultry, fish and sheep on the livestock side. Products reach more than 100 countries, with major brands including Apoquel, Simparica and Cytopoint.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.